Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

5.01
Delayed Data
As of 3:59pm ET
 +0.13 / +2.66%
Today’s Change
3.70
Today|||52-Week Range
10.40
-38.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues5.7M5.0M4.7M7.1M
 
 
 
 
 
Cost of Goods Sold1.2M1.4M2.8M1.4M
 
 
 
 
 
Depreciation And Amortization544.0K546.0K546.0K528.0K
 
 
 
 
 
 
Operating ExpensesGross Income4.0M3.0M1.4M5.1M
 
 
 
 
 
General Expenses11.5M8.0M8.3M6.3M
 
 
 
 
 
Research And Development3.1M15.0K62.0K0.00
 
 
 
 
Total Operating Expenses13.2M10.0M11.7M8.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.4M-5.0M-7.0M-1.1M
 
 
 
 
 
Interest Expense On Debt560.0K542.0K484.0K405.0K
 
 
 
 
 
Other Expenses697.0K-75.0K-305.0K347.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.3M-5.6M-7.8M-1.2M
 
 
 
 
 
Income Taxes-73.0K-169.0K-360.0K-45.0K
 
 
 
 
 
Net Income-7.4M-5.8M-7.4M-1.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.2M18.8M20.1M20.3M
 
 
 
 
 
Shares To Calculate EPS Diluted17.2M18.8M20.1M20.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.43-$0.31-$0.37-$0.06
 
 
 
 
 
EPS Diluted-$0.43-$0.31-$0.37-$0.06